Why did this defence stock soar 32% in 2 days? Zoomed 57% so far in May

Share price of Apollo Micro Systems: Shares of Apollo Micro Systems hit a new high of ₹183.60, soaring 18 per cent on the BSE in Tuesday's intra-day trade amid heavy volumes, in an otherwise subdued market, after the company received export order worth of ₹114 crore.
In the past two trading days, the stock price of this smallcap aerospace & defence company has zoomed 32 per cent. Thus far in the month of May 2025, it has rallied 57 per cent.
At 12:25 PM, Apollo Micro Systems was quoting 17 per cent higher at ₹180.70, as compared to 0.22 per cent decline in the BSE Sensex. The average trading volumes on the counter jumped over two-fold. As many as a combined 59.75 million equity shares representing 19.5 per cent of total equity of Apollo Micro Systems have changed hands on the NSE and BSE.
What is behind the rally in Apollo Micro Systems?
Apollo Micro Systems informed stock exchanges that in the ordinary course of its business, the company has received an export order valued at $13,366,500 (equivalent to approximately ₹113.81 crore) for the development of an Avionic System.
This project pertains to the development of an advanced avionics system intended for use in civil and military aircraft applications. However, due to the sensitive nature of the engagement, specific technical and programme details are bound by a Non-Disclosure Agreement (NDA) with the customer, the company said.
Meanwhile, on May 5, 2025, Apollo Defence Industries Pvt Ltd (ADIPL), a subsidiary of Apollo Micro Systems, entered into a Share Purchase Agreement (SPA) to acquire 100 per cent equity stake in IDL Explosives for a total consideration of ₹107 crore, in an all-cash transaction. ALSO READ |
IDL Explosives is engaged in the manufacture of full range packaged and bulk explosive specifically engineered for mining and infrastructure projects. Moreover it also offers an extensive range of cartridge explosives. It has served the Indian mining and Infrastructure Industry.
The explosive market size is expected to see strong growth in the next few years. The surge in government spending on the defense sectors in various countries including the US, China, India, Russia, the UK and France is projected to be a major driver for the growth of the explosive market during the period.
The growth in the forecast period can be attributed to an increase in territorial and political conflict, global population growth and urbanisation, increasing infrastructure development expenditure by governments and increasing construction activities.
Strong outlook
Looking ahead, the management of Apollo Micro Systems expects revenue to grow at a compounded annual growth rate (CAGR) of 45 per cent to 50 per cent over the next two years — driven solely by the core business, excluding any contribution from the recent acquisition.
This growth is underpinned by a healthy order book and multiple products entering the production phase. Operating margins are projected to improve in the first half of FY26 due to favorable operating leverage and product mix. However, ongoing and planned capital investments are expected to moderate margin expansion in the latter half of FY26 and into FY27. ALSO READ |
Recent geopolitical developments — particularly the India–Pakistan conflict — have further accelerated demand for indigenous defence solutions. Several of our systems were successfully tested and demonstrated during this period, generating major interest and engagement across the defence value chain.
About Apollo Micro Systems
Apollo Micro Systems is a Hyderabad-based company engaged in the business of electronic, electro-mechanical, engineering designs, manufacturing and supply. The company specialises in the design, development and sale of high-performance, mission and time critical solutions to defence, space and home land security for the Ministry of Defence, government controlled public sector undertakings and private sector companies. Apollo Micro Systems also offers custom built COTS (Commercially off-the shelf) solutions based on specific requirements for defence and space customers. Its addressable industries include railways, automotive and home land security.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Business Standard

25 minutes ago

• Business Standard

Influx Healthtech IPO booked 200x; check allotment, GMP, listing date

Influx Healthtech IPO allotment status: The basis of allotment of shares for Influx Healthtech is expected to be finalised today, Monday, June 23, 2025. The initial public offering (IPO) of Influx Healthtech, which closed for subscription on Friday, June 20, received a robust response from investors, with the offering being over subscribed by over 201 times. Investors bid for 817.53 million equity shares, which was 201.4 times the public issue size of 4.05 million shares, through 220,338 applications. After the allotment process is completed, investors can verify their IPO allotment status by visiting the official websites of the National Stock Exchange (NSE) and Maashitla Securities, the designated registrar for the Influx Healthtech IPO. Alternatively, they can use the direct links provided below to check their allotment status online: Check Influx Healthtech IPO allotment status on NSE: Check Influx Healthtech IPO allotment status on Maashitla Securities: Influx Healthtech IPO grey market premium (GMP) The unlisted shares of Influx Healthtech were trading at ₹118 in the grey market, commanding a premium of ₹22 or 22.3 per cent compared to the upper price band of ₹96 per share, according to sources tracking unofficial markets. Influx Healthtech IPO details The Mumbai-based company aims to raise ₹58.57 crore through a combination of a fresh issue of 5 million equity shares and an offer for sale (OFS) of 1.1 million equity shares at a price band of ₹91-96 per share. Shares of Influx Healthtech are scheduled to be listed on the NSE SME platform on Wednesday, June 25. Rarever Financial Advisors is the sole book-running lead manager. According to the red herring prospectus (RHP), the company intends to use the net fresh issue proceeds for the set up of the manufacturing facility Nutraceutical Division, a manufacturing facility for the Veterinary Food Division; purchase of machinery for Homecare and Cosmetic Division, and general corporate purposes. About Influx Healthtech Incorporated in 2020, Mumbai-based Influx Healthtech is a healthcare-focused company specialising in contract manufacturing. It operates a manufacturing facility located in Thane, Maharashtra. The company produces Dietary and Nutritional Supplements, Cosmetics, Ayurvedic/Herbal Products, Veterinary Feed Supplements, care products, Active Pharmaceutical Ingredients (APIs), and finished dosage forms, including tablets, capsules, and injectables.

Business Standard

25 minutes ago

• Business Standard

Vedanta, 2 others to trade ex-dividend on June 24; do you own any?

Dividend stocks: Shares of Vedanta, Polycab India, and Alkyl Amines Chemicals are set to remain in spotlight today, June 23, following their announcement of dividend rewards for their shareholders. These shares, BSE data suggest, will trade ex-dividend tomorrow, June 24. The ex-dividend date is when a stock starts trading without the right to receive the declared dividend. To be eligible, investors must own the stock before this date. Companies determine the list of eligible shareholders based on their records on the record date. Vedanta dividend 2025 Metal and mining major Vedanta informed the exchanges that its board of directors has considered and approved the first interim dividend of ₹7 per equity share on face value of ₹1 per equity share for the Financial Year 2025-26, amounting to ₹2,737 crore. The record date for the purpose of payment of dividend, Vedanta said, shall be Tuesday, June 24, 2025, and the interim dividend shall be duly paid within the stipulated timelines as prescribed under law. Polycab India dividend 2025 Wires and cables manufacturer Polycab India 's board has recommended a dividend @ 350 per cent i.e. ₹35 per equity share of face value of ₹10 each for the Financial Year 2024-25, subject to approval of members at the ensuing Annual General Meeting. "The dividend, if approved by the members in the ensuing Annual General Meeting, will be paid on or before 30 days from the date of the Annual General Meeting," said the company in an exchange filing. Alkyl Amines Chemicals dividend 2025 Specialty chemicals manufacturer Alkyl Amines Chemicals has informed the exchanges that its board has recommended a final dividend of ₹10 per equity share of ₹2 each (i.e., 500 per cent) for the Financial Year (F.Y.) 2024-25. The dividend is, however, subject to approval by the shareholders at the ensuing Annual General Meeting. Alkyl Amines Chemicals has fixed Tuesday, June 24, 2025, as the 'record date' for determining entitlement of members to dividend for the financial year ended March 31, 2025, if approved at the AGM.

Business Standard

25 minutes ago

• Business Standard

Arisinfra Solutions IPO allotment today; check status, GMP, listing date

Arisinfra Solutions IPO allotment status: The basis of allotment for the Arisinfra Solutions IPO shares is likely to be finalised today, Monday, June 23, 2025. The public offering closed for subscription on Friday, June 20, 2025, receiving decent participation from investors and getting oversubscribed by 2.65 times. Here's how to check Arisinfra Solutions IPO online Once the Arisinfra Solutions IPO allotment is finalised, investors can check their status on the official websites of BSE, NSE, or MUFG Intime India (erstwhile Link Intime), the registrar for the issue. Alternatively, investors can use these direct links to check the Arisinfra Solutions IPO allotment status directly: Arisinfra Solutions IPO final subscription status The ₹499.60 crore public offering of Arisinfra Solutions, offered at a price band of ₹210–222 with a lot size of 67 shares, received bids for 3,46,72,835 shares against the 1,30,84,656 shares offered. This led to an oversubscription of 2.65 times by the end of the subscription period, according to data available on the BSE. Arisinfra Solutions IPO witnessed the highest participation from the retail investors who subscribed to 5.59 times the portion reserved for them, non-institutional investors (NIIs) at 3.14 times, and qualified institutional buyers (QIBs) at 1.42 times. Arisinfra Solutions IPO grey market premium (GMP) today According to sources tracking unofficial market activities, the unlisted shares of Arisinfra Solutions were seen trading flat at ₹222 per share. Thus, the grey market premium (GMP) for Arisinfra Solutions IPO remains nil on Monday. Arisinfra Solutions IPO likely listing price Shares of Arisinfra Solutions are scheduled to list on the BSE and NSE on Wednesday, June 25, 2025. The current grey market trends indicate a flat listing of Arisinfra Solutions shares. However, these estimates may vary, as the grey market is unregulated, and GMP should not be considered a reliable indicator of performance. About Arisinfra Solutions Incorporated in 2021, Arisinfra Solutions is a B2B technology-driven platform that simplifies procurement processes for construction and infrastructure companies. The company delivers a range of construction materials, including steel, cement, and aggregates. The company's product portfolio includes GI pipes, MS wire, and OPC bulk cement. Arisinfra Solutions has a subsidiary, ArisUnitern Re Solutions Private, which provides value-added services to real estate developers.